MARK L PERRY
CIK 1190270 · last filed 2024-06-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.00M
Companies
3
Total Filings
53
Lifetime Open-Market Net
-$55.13M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVDA | Director | 14,612 | $205.19 | $3.00M | -$51.09M | 30 | 2024-06-26 |
| Global Blood Therapeutics, Inc. (GBT) Delisted | Director | 0 | $68.49 | $0 | -$4.09M | 11 | 2022-10-06 |
| MyoKardia, Inc. (MYOK) Delisted | Director | 27,708 | — | — | $50.0K | 9 | 2020-06-23 |
Recent Filings · Page 3 of 6
53 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-13 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | — | -$3.00M | EDGAR |
| 2020-02-20 | NVDA | Sell (S) | −8,752 | -$2.56M | EDGAR |
| 2019-06-20 | Global Blood Therapeutics, Inc. (GBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-17 | MyoKardia, Inc. (MYOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-28 | NVDA | Grant (A) | +1,258 | $0 | EDGAR |
| 2018-06-22 | Global Blood Therapeutics, Inc. (GBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-14 | MyoKardia, Inc. (MYOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-21 | NVDA | Grant (A) | +963 | $0 | EDGAR |
| 2018-02-13 | NVDA | Sell (S) | −17,307 | -$3.94M | EDGAR |
| 2017-08-16 | NVDA | Sell (S) | −16,281 | -$2.64M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.